U.S. Vaccine Panel Reverses Stance on COVID mRNA Shots

A significant update has emerged from a U.S. federal vaccine advisory panel regarding COVID mRNA vaccines. According to the Washington Post, the panel has abandoned its previous push against these vaccines, citing reliable sources.

Health and Human Services advisers under Robert F. Kennedy Jr. had initially considered halting recommendations for mRNA shots. However, the idea has been shelved. In September last year, the panel discarded a broad recommendation for COVID vaccines, favoring a model of shared decision-making with healthcare providers. Andrew Nixon, an HHS spokesperson, confirmed that the committee has not changed its September 2025 decision regarding COVID vaccines on CDC immunization schedules. The CDC's advisory panel is expected to convene next week to decide on the recommended vaccines for Americans.

Despite assertions by Kennedy Jr., a known anti-vaccine advocate, about the ineffectiveness of these vaccines against upper respiratory infections like COVID and flu, scientific evidence supports their efficacy. Produced by Pfizer-BioNTech and Moderna, these vaccines employ mRNA technology to instruct cells to make a virus protein, enhancing immunity without using live or inactive viruses.